Nautilus Biotechnology earnings were -$70.2M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest NAUT earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$16.4M, down 8.7% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, NAUT reported annual earnings of -$63.7M, with 9.9% growth.
Nautilus Biotechnology Earnings Reports & History FAQ
What were Nautilus Biotechnology's earnings last quarter?
Nautilus Biotechnology (NASDAQ: NAUT) reported Q3 2024 earnings per share (EPS) of -$0.13, up 0% year over year. Total NAUT earnings for the quarter were -$16.45 million. In the same quarter last year, Nautilus Biotechnology's earnings per share (EPS) was -$0.13.
Is Nautilus Biotechnology profitable or losing money?
As of the last Nautilus Biotechnology earnings report, Nautilus Biotechnology is currently losing money. Nautilus Biotechnology's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$70.21 million, a 16.9% increase year over year.
What was NAUT's earnings growth in the past year?
As of Nautilus Biotechnology's earnings date in Q1 2025, Nautilus Biotechnology's earnings has grown year over year. NAUT earnings in the past year totalled -$70.21 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.